Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 101

1.

Clinicopathological features of HCV-positive splenic diffuse large B cell lymphoma.

Shimono J, Miyoshi H, Arakawa F, Yamada K, Sugio T, Miyawaki K, Eto T, Miyagishima T, Kato K, Nagafuji K, Akashi K, Teshima T, Ohshima K.

Ann Hematol. 2019 May;98(5):1197-1207. doi: 10.1007/s00277-019-03628-8. Epub 2019 Feb 7.

PMID:
30729289
2.

Splenic large B-cell lymphoma in patients with hepatitis C virus infection.

Takeshita M, Sakai H, Okamura S, Oshiro Y, Higaki K, Nakashima O, Uike N, Yamamoto I, Kinjo M, Matsubara F.

Hum Pathol. 2005 Aug;36(8):878-85.

PMID:
16112004
3.

Early-stage splenic diffuse large B-cell lymphoma is highly associated with hepatitis C virus infection.

Yu SC, Lin CW.

Kaohsiung J Med Sci. 2013 Mar;29(3):150-6. doi: 10.1016/j.kjms.2012.08.025. Epub 2012 Nov 20.

4.

Prevalence of hepatitis C virus infection in cases of B-cell lymphoma in Japan.

Takeshita M, Sakai H, Okamura S, Higaki K, Oshiro Y, Uike N, Yamamoto I, Shimamatsu K, Muranaka T.

Histopathology. 2006 Jan;48(2):189-98.

PMID:
16405668
5.

Clinicopathological analysis of primary splenic diffuse large B-cell lymphoma.

Shimono J, Miyoshi H, Kiyasu J, Sato K, Kamimura T, Eto T, Miyagishima T, Nagafuji K, Teshima T, Ohshima K.

Br J Haematol. 2017 Sep;178(5):719-727. doi: 10.1111/bjh.14736. Epub 2017 May 11.

PMID:
28493517
6.

In Situ Hepatitis C NS3 Protein Detection Is Associated with High Grade Features in Hepatitis C-Associated B-Cell Non-Hodgkin Lymphomas.

Canioni D, Michot JM, Rabiega P, Molina TJ, Charlotte F, Lazure T, Davi F, Settegrana C, Berger F, Alric L, Cacoub P, Terrier B, Suarez F, Sibon D, Dupuis J, Feray C, Tilly H, Pol S, Deau Fischer B, Roulland S, Thieblemont C, Leblond V, Carrat F, Hermine O, Besson C; national ANRS HC13 LymphoC study.

PLoS One. 2016 Jun 3;11(6):e0156384. doi: 10.1371/journal.pone.0156384. eCollection 2016.

7.

Hepatitis C virus and diffuse large B-cell lymphoma: Pathogenesis, behavior and treatment.

Visco C, Finotto S.

World J Gastroenterol. 2014 Aug 28;20(32):11054-61. doi: 10.3748/wjg.v20.i32.11054. Review.

8.

Clinicopathologic characteristics and outcomes of transformed diffuse large B-cell lymphoma in hepatitis C virus-infected patients.

Hosry J, Miranda RN, Samaniego F, Economides MP, Torres HA.

Int J Cancer. 2018 Mar 1;142(5):940-948. doi: 10.1002/ijc.31110. Epub 2017 Nov 3.

9.

Epstein-Barr virus (EBV) positive diffuse large B cell lymphoma of the elderly-experience of a single center from Turkey.

Ozsan N, Cagirgan S, Saydam G, Gunes A, Hekimgil M.

Pathol Res Pract. 2013 Aug;209(8):471-8. doi: 10.1016/j.prp.2013.04.014. Epub 2013 May 9.

PMID:
23726928
10.

Dysregulation of global microRNA expression in splenic marginal zone lymphoma and influence of chronic hepatitis C virus infection.

Peveling-Oberhag J, Crisman G, Schmidt A, Döring C, Lucioni M, Arcaini L, Rattotti S, Hartmann S, Piiper A, Hofmann WP, Paulli M, Küppers R, Zeuzem S, Hansmann ML.

Leukemia. 2012 Jul;26(7):1654-62. doi: 10.1038/leu.2012.29. Epub 2012 Feb 6.

PMID:
22307176
11.

Development of EBV-encoded small RNA targeted PCR to classify EBV positive diffuse large B-cell lymphoma (DLBCL) of the elderly.

Lee J, Park M, Lee MH, Woo HJ, Kim HW, Yang JY, Eom YB, Kim SH, Yoo C, Kim JB.

Int J Clin Exp Pathol. 2015 Jul 1;8(7):7859-68. eCollection 2015.

12.

Efficacy and prognosis of antiviral therapy on hepatitis C following treatment of lymphoma in HCV-positive diffuse large-cell lymphoma.

Tsutsumi Y, Nakayama C, Kamada K, Kikuchi R, Kudo D, Ito S, Matsuoka S, Shiratori S, Yamamoto Y, Naruse H, Teshima T.

Ann Hematol. 2017 Dec;96(12):2057-2061. doi: 10.1007/s00277-017-3129-0. Epub 2017 Sep 22.

13.

HCV non-structural protein 3 and HCV RNA genome in non-Hodgkin lymphoma and transition of the serum HCV RNA level: a retrospective analysis in one institution.

Shiratori S, Tsutsumi Y, Kawamura T, Kudo K, Shimoyama N, Masauzi N, Tanaka J, Asaka M, Imamura M.

Int J Hematol. 2008 Apr;87(3):298-302. doi: 10.1007/s12185-008-0050-2. Epub 2008 Mar 6.

PMID:
18320139
14.

Etiological factors in primary hepatic B-cell lymphoma.

Kikuma K, Watanabe J, Oshiro Y, Shimogama T, Honda Y, Okamura S, Higaki K, Uike N, Soda T, Momosaki S, Yokota T, Toyoshima S, Takeshita M.

Virchows Arch. 2012 Apr;460(4):379-87. doi: 10.1007/s00428-012-1199-x. Epub 2012 Mar 7.

15.

The NOTCH pathway is recurrently mutated in diffuse large B-cell lymphoma associated with hepatitis C virus infection.

Arcaini L, Rossi D, Lucioni M, Nicola M, Bruscaggin A, Fiaccadori V, Riboni R, Ramponi A, Ferretti VV, Cresta S, Casaluci GM, Bonfichi M, Gotti M, Merli M, Maffi A, Arra M, Varettoni M, Rattotti S, Morello L, Guerrera ML, Sciarra R, Gaidano G, Cazzola M, Paulli M.

Haematologica. 2015 Feb;100(2):246-52. doi: 10.3324/haematol.2014.116855. Epub 2014 Nov 7.

16.

Clinical impact of serum survivin positivity and tissue expression of EBV-encoded RNA in diffuse large B-cell lymphoma patients treated with rituximab-CHOP.

Hong JY, Ryu KJ, Park C, Hong M, Ko YH, Kim WS, Kim SJ.

Oncotarget. 2017 Feb 21;8(8):13782-13791. doi: 10.18632/oncotarget.14636.

17.

[Tumors of lymphoid and hematopoietic tissue of spleen: a clinicopathologic analysis of 53 cases].

Chen DB, Shen DH, Zhang H, Wang Y, Song QJ, Yang SM, Fang XZ.

Zhonghua Bing Li Xue Za Zhi. 2017 Nov 8;46(11):775-781. doi: 10.3760/cma.j.issn.0529-5807.2017.11.008. Chinese.

PMID:
29136691
18.

[Immunophenotypes and prognosis of diffuse large B-cell lymphoma: a study of 500 cases].

Luo DL, Liu YH, Zhuang HG, Li L, Xu FP, Zhang F, Luo XL, Xu J.

Zhonghua Bing Li Xue Za Zhi. 2011 Apr;40(4):235-9. Chinese.

PMID:
21615996
19.

Primary splenic diffuse large B-cell lymphoma manifesting in red pulp.

Kashimura M, Noro M, Akikusa B, Okuhara A, Momose S, Miura I, Kojima M, Tamaru J.

Virchows Arch. 2008 Nov;453(5):501-9. doi: 10.1007/s00428-008-0673-y. Epub 2008 Sep 26.

PMID:
18818942
20.

The impact of Epstein-Barr virus status on clinical outcome in diffuse large B-cell lymphoma.

Park S, Lee J, Ko YH, Han A, Jun HJ, Lee SC, Hwang IG, Park YH, Ahn JS, Jung CW, Kim K, Ahn YC, Kang WK, Park K, Kim WS.

Blood. 2007 Aug 1;110(3):972-8. Epub 2007 Mar 30.

PMID:
17400912

Supplemental Content

Support Center